Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,016.00    0.00 (0.00%)
Bid:
1,022.00
Ask:
1,026.00
Spread: 4.00 (0.391%)
Market Cap: £145.79b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Buyback programme: transactions 4-11Feb

12 Feb 2026 15:02

RNS Number : 8258S
Banco Santander S.A.
12 February 2026
Β 

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

Reference is made to our notice of inside information of 4 February 2026 (official registry number 3077) (the "Buyback Commencement Communication"), relating to the buyback programme of own shares (the "Buyback Programme") approved by the Board of Directors of Banco Santander.

Β 

Pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Bank informs of the transactions carried out over its own shares between 4 and 11 February (both inclusive).

Β 

The cash amount of the shares purchased to 11 February 2026 as a result of the execution of the Buyback Programme amounts to 603,165,936 Euros, which represents approximately 12% of the maximum investment amount of the Buyback Programme. The programme was announced together with its other characteristics through the Buyback Commencement Communication. With these purchases, the Bank has repurchased approximately 15.6% of its outstanding shares as of 2021.

Β 

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (€)

04/02/2026

SAN

Purchase

XMAD

5,219,000

10.7383

04/02/2026

SAN

Purchase

CEUX

1,934,000

10.7379

04/02/2026

SAN

Purchase

TQEX

236,000

10.7343

04/02/2026

SAN

Purchase

AQEU

545,000

10.7380

05/02/2026

SAN

Purchase

XMAD

5,710,000

10.5958

05/02/2026

SAN

Purchase

CEUX

2,346,000

10.5962

05/02/2026

SAN

Purchase

TQEX

307,000

10.5984

05/02/2026

SAN

Purchase

AQEU

600,000

10.5985

06/02/2026

SAN

Purchase

XMAD

6,005,000

10.5772

06/02/2026

SAN

Purchase

CEUX

2,560,000

10.5759

06/02/2026

SAN

Purchase

TQEX

329,000

10.5716

06/02/2026

SAN

Purchase

AQEU

638,000

10.5760

09/02/2026

SAN

Purchase

XMAD

6,136,000

10.7730

09/02/2026

SAN

Purchase

CEUX

2,667,000

10.7716

09/02/2026

SAN

Purchase

TQEX

347,000

10.7733

09/02/2026

SAN

Purchase

AQEU

665,000

10.7602

10/02/2026

SAN

Purchase

XMAD

6,138,000

10.9296

10/02/2026

SAN

Purchase

CEUX

2,859,000

10.9397

10/02/2026

SAN

Purchase

TQEX

353,000

10.9291

10/02/2026

SAN

Purchase

AQEU

702,000

10.9393

11/02/2026

SAN

Purchase

XMAD

6,138,000

10.6038

11/02/2026

SAN

Purchase

CEUX

2,859,000

10.5932

11/02/2026

SAN

Purchase

TQEX

353,000

10.6078

11/02/2026

SAN

Purchase

AQEU

702,000

10.5957

TOTAL

56,348,000

Β 

Β 

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

Β 

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

Detailed information of the transactions carried out within the referred period is attached as Annex I.

Β 

Boadilla del Monte (Madrid), 12 February 2026

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 04/02/2026 and 11/02/2026 (both inclusive)

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSEALAAFSXKEFA
Date   Source Headline
6th May 20257:00 amRNSPresentation to analysts about sale of San Polska
6th May 20257:00 amRNSSantander announces sale of 49%of Santander Polska
6th May 20257:00 amRNSAnalysts meeting announcement
30th Apr 202512:41 pmRNSTotal Voting Rights
30th Apr 20257:00 amRNS1Q 2025 Results report & analyst presentation
30th Apr 20257:00 amRNS1Q 2025 Results Press Release
29th Apr 202511:11 amRNSBuyback programme: Transactions 23-28Apr
28th Apr 20251:56 pmRNSSantander statement
23rd Apr 202511:59 amRNS1st Quarter 2025 Results Notice
23rd Apr 202511:11 amRNSBuyback programme: transactions 11-22Apr
11th Apr 202511:13 amRNSBuyback programme: transactions 3-10Apr
4th Apr 20253:09 pmRNS2025 AGM - Resolutions
4th Apr 20257:08 amRNSSantander expects growth & 2025 targets reaffirmed
3rd Apr 202511:13 amRNSBuyback programme: transactions 27Mar-2Apr
31st Mar 20254:07 pmRNSTotal Voting Rights
27th Mar 202511:15 amRNSTransaction in Own Shares
20th Mar 202511:10 amRNSBuyback programme: transactions 13Mar-19Mar
17th Mar 20255:31 pmRNSDirector/PDMR Shareholding
14th Mar 20251:27 pmRNSDirector/PDMR Shareholding
14th Mar 20251:22 pmRNSDirector/PDMR Shareholding
13th Mar 202511:06 amRNSBuyback programme: transactions 6 Mar -12 Mar
6th Mar 202511:14 amRNSBuyback programme: transactions 27 Feb- 5 Mar
5th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20256:23 pmRNSDirector/PDMR Shareholding
28th Feb 20256:19 pmRNSDirector/PDMR Shareholding
28th Feb 20256:14 pmRNSDirector/PDMR Shareholding
28th Feb 20256:08 pmRNSDirector/PDMR Shareholding
28th Feb 202510:52 amRNSTotal Voting Rights
28th Feb 202510:51 amRNSNotice of AGM
28th Feb 202510:15 amRNS2024 UK Annual Report
27th Feb 202511:12 amRNSBuyback programme: transactions 20Feb-26Feb
26th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSDividend declaration & agreement to call 2025 AGM
20th Feb 202511:12 amRNSBuyback programme: transactions 13Feb-19Feb
19th Feb 20255:46 pmRNSDirector/PDMR Shareholding
14th Feb 20251:10 pmRNSReplaces Invitation to purchase certain instrument
13th Feb 202512:00 pmRNSInvitation to purchase certain instruments
13th Feb 202511:18 amRNSBuyback programme: transactions 6Feb-12Feb
12th Feb 20253:43 pmRNSRating granted by Fitch Ratings
7th Feb 20251:49 pmRNSDirector/PDMR Shareholding
7th Feb 20251:48 pmRNSDirector/PDMR Shareholding
6th Feb 20258:00 amRNSInvitation to purchase certain instruments
5th Feb 20257:00 amRNS2024 Results - Press release
5th Feb 20257:00 amRNS2024 Financial report & Earnings presentation
5th Feb 20257:00 amRNSCommencement of a program to repurchase own shares
31st Jan 20251:14 pmRNSTotal Voting Rights
29th Jan 202512:44 pmRNSForm 8.3 - Smith (DS) PLC
29th Jan 202511:07 amRNSNotice of 2024 Results Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.